Brazil Artificial Organs & Bionic Implants Market Size, 2031

Brazil Artificial Organs & Bionic Implants Market Size, 2031

Segments - Brazil Artificial Organs & Bionic Implants Market by Products (Artificial Organs [Artificial Kidney, Artificial Heart, and Others], Bionics [Orthopedic Bionic, Vision Bionics, Cardiac Bionics, and Others]), and Country - Brazil Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vineet
Fact-checked by : Vineet Pandey
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-2790 | 4.8 Rating | 82 Reviews | 185 Pages | Format : PDF Excel PPT

Report Description


The Brazil Artificial Organs & Bionic Implants Market size was valued at USD XX Billion in 2022 and is expected to surpass USD XX Billion by 2031, expanding at a CAGR of 11.69% during the forecast period, 2023 – 2031The growth of the market is attributed to growing elderly population and unhealthy lifestyle bringing various diseases such as cardiac arrest, liver sorosis and others also rising instances of accidents.

When an organ in a person's body is destroyed due to accident or disease, organ transplantation becomes necessary. However, there are much fewer organ donors than there are people who need them. Although there is a potential that the transplanted organ will be rejected once it has been implanted. This indicates that the recipient's immune system is unable to accept the organ.

Brazil Artificial Organs & Bionic Implants Market Outlook

The market size for artificial organs and bionic implants is now being pushed by the fact that a huge number of patients require organ transplantation, despite the fact that not everyone can receive an organ due to a lack of donors.

According to the Brazilian Association of Organ Transplantation (ABTO)— number of donors in Brazil is sixteen donors on per million individuals. The average waiting period for a kidney transplant from a dead donor is three years.

According to survey conducted by Med Plus in Brazil infectious infections (30.2%), family rejection (37.2%), and clinical contraindications were the most common reasons for non-donation (32.6 percent). The majority of potential donors were overlooked in the middle of the night (54.8 percent) and at the emergency room (80.9 percent).

According to the Brazilian Dialysis Census of July 2018, the total number of dialysis patients was predicted to be 133,464, with a prevalence rate of 640 patients per million people (pmp). 92.3 % of the patients on dialysis were on hemodialysis, 7.7% were on peritoneal dialysis, and 29,545 (22.1 percent) were on the transplant waiting list.

Recent developments in the disciplines of artificial organs and regenerative medicine are now coming together in the realms of organ transplantation and bioengineering to help patients with end-stage renal illness overcome ongoing hurdles.

The transplantable bioengineered kidney with the implanted artificial renal assist device (RAD). Micromachining methods are used in the artificial RAD concept to create a biohybrid system that can imitate renal shape and function.

Hearing devices that measure physical activity and detect falls are being developed by Starkey Hearing Technologies. It's also developing new sensors, such as heart rate monitors, as a first step in bringing hearing aids into the realm of health and wellness.

Surface modification of titanium implants for enhancing the corrosion resistance and related properties of biomaterials are focus of manufactures as
On March 2021, The US Patent Office gave permission of patent No. 10,933,183 for the updated version of the wearable artificial organs (WAK) according to Victor Gura, MD, chairman and chief scientific officer of Wearable Artificial Organs Inc. Patients with end-stage renal disease are hampered by current fixed dialysis devices, which limit their mobility and activity.

The new gadget is significantly lighter and smaller than the 1.0 and 2.0 generations. Three clinical studies in Vicenza, Italy, London, United Kingdom, and Seattle, Washington, successfully tested the proof-of-concept model 2.0, an 11-pound device. The WAK 3.0 is 2 pounds in weight and runs on a rechargeable battery.

Covid 19 has affected the market negatively as governments announced national emergency in the country leads to delay or halt all the surgeries as it increases the risk of exposure for the virus into the patient.

  • Rising elderly population is expected to boost the market during the forecast period.

  • Introduction of portable implant devices is projected to drive the market in the coming years.

  • Absence of organ donors and increasing instances of organ failure are anticipated to fuel the market.

  • Growing burden of diseases, unhealthy life styles and poor dietary among population are expected to spur the market in the coming years.

  • Rising accidents causing organ damage or physical disabilities is estimated to fuel the market.

  • Increasing cases of genetic disorders is anticipated to push the market.

  • Organ implant is a very high-cost procedure which act as key challenges that can hamper the market growth.

  • Organ rejection patients’ body after organ implantation is the major factor to restrict the market.

  • Technological advancements in genetic engineering and biomedicals are creating a significant opportunity for the market players.

Scope of the Report

The report on the Brazil artificial organs & bionic implants market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Brazil Artificial Organs & Bionic Implants - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Products (Artificial Organs [Artificial Kidney, Artificial Heart, and Others], Bionics [Orthopedic Bionic, Vision Bionics, Cardiac Bionics, and Others])

Country Scope

Brazil

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Medtronic plc; Ottobock; Zimmer Biomet; Ossur; Boston Scientific Corporation

Brazil Artificial Organs & Bionic Implants Market Segment Insights

The cardiac bionics segment is projected to hold a large market share

Based on products, the Brazil artificial organs & bionic implants market is divided into artificial organs, and bionics. The bionics segment is further segmented into orthopedic bionic, vision bionics, cardiac bionics, and others. The cardiac bionics expected to account for a key share of the market during the forecast period owing to increasing load of chronic heart diseases also they are cost effective and less chances of organ rejection are there.

Brazil Artificial Organs & Bionic Implants Market Products

Segments

The Brazil artificial organs & bionic implants market has been segmented on the basis of

Products

  • Artificial Organs
    • Artificial Kidney
    • Artificial Heart
    • Others
  • Bionics
    • Orthopedic Bionic
    • Vision Bionics
    • Cardiac Bionics
    • Others

Country

  • Brazil

Key Players

  • Medtronic plc
  • Ottobock
  • Zimmer Biomet
  • Ossur
  • Boston Scientific Corporation

Competitive Landscape

Key players competing in the Brazil artificial organs & bionic implants market include Medtronic plc; Ottobock; Zimmer Biomet; Ossur; Boston Scientific Corporation.

Some of these players are focusing on business strategies including partnerships, collaborations, capacity expansion, and product launches to increase their market shares.

Brazil Artificial Organs & Bionic Implants Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Artificial Organs & Bionic Implants Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Artificial Organs & Bionic Implants Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Artificial Organs & Bionic Implants Market - Supply Chain
  4.5. Global Artificial Organs & Bionic Implants Market Forecast
     4.5.1. Artificial Organs & Bionic Implants Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Artificial Organs & Bionic Implants Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Artificial Organs & Bionic Implants Market Absolute $ Opportunity
5. Global Artificial Organs & Bionic Implants Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Artificial Organs & Bionic Implants Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
6. North America Artificial Organs & Bionic Implants Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
7. Latin America Artificial Organs & Bionic Implants Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
8. Europe Artificial Organs & Bionic Implants Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
9. Asia Pacific Artificial Organs & Bionic Implants Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
10. Middle East & Africa Artificial Organs & Bionic Implants Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Artificial Organs & Bionic Implants Market: Market Share Analysis
  11.2. Artificial Organs & Bionic Implants Distributors and Customers
  11.3. Artificial Organs & Bionic Implants Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Medtronic plc
     11.4.2. Ottobock
     11.4.3. Zimmer Biomet
     11.4.4. Ossur
     11.4.5. Boston Scientific Corporation

Methodology

Our Clients

Nestle SA
Microsoft
Deloitte
General Mills
sinopec
Pfizer
The John Holland Group
Siemens Healthcare